BibTex RIS Kaynak Göster

Yıl 2004, Cilt: 2 Sayı: 4, 117 - 121, 01.12.2004

Ünsal Günay Birol Baytan Adalet Meral Güneş Özcan Bör

Öz

Kaynakça

  • 1. Goodnight SH, Griffin JH. Hereditary Trombophilia. In: Beutler E, Licht￾man MA, Coller BS, Seligsohn U (ed.). Willams Hematology. 6th editi￾on. Pensilvellia. McGraw-Hill; 2001. p.1697-707.
  • 2. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
  • 3. Cate T.H, Somme›jer D. W, Lev› M. Disseminated intravascular caogu￾lation in the new millennium. The Hematology Journal 2002; 3:86-95.
  • 4. Sjoukje H. S, Spek C. A, Cate T.H. Disseminated intravascular caogula￾tion. The Hematology Journal 2003; 4:295-302.
  • 5. Abildgaard CF, JJ Corrigan, RA Seter, JV Simone, I Schulman. Menin￾gococcemia assosiated with intravascular coagulation. Pediatrics (abst) 1967; 40:78.
  • 6. F Fourrier, C Chopin, J Goudemand, S Hendryx, C Caron, A Rime, A Ma￾rey. Septic shock, multiple organ failure, and disseminated intravascu￾lar coagulation. Compared patterns of antitrombin, protein C, and pro￾tein S deficiencies. Chest 2000; 101: 816-23.
  • 7. Levi M, Cate H, Van Der Poll T, Deventer S. J. Pathogenesis of dissemi￾nated intravascular coagulation in sepsis. N Engl J Med 1993; 8: 1132-4.
  • 8. Bick R.L, Strauss J.F, Frenkel E.P. Thrombosis and hemorrage in onco￾logy patients. Hematology Oncology Clinics North America 2001; 10: 875-907.
  • 9. Levi M, Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-92
  • 10. Stormorken H. ‹nterrelationships between the coagulation, the fibri￾nolytic and the kallikrein and kinin system. Scand. Journal Hematology (abst) 1998; 13:66-9.
  • 11. Rodger L.B, B.A. Frenkel, E.P Frenkel. Diseminated intravaskülar coagu￾lat›on:clinical and pathophysiologial mechanisms and manifestations. 15 th international congress on thrombosis. Stockholm. Bildiri Özet Ki￾tab›. S. 209-17, 1998.
  • 12. Rock A. Consumption Coagulopathy. In: Behrman R.E, Kliegman M.R, Arvin M.A, Nelson W.E (ed.) Nelson Textbook of Pediatrics. 15th.editi￾on. W.B. Saunders company 1996: p 430-31.
  • 13. Karado¤an ‹. Yayg›n damar içi p›ht›laflmas› sendromu. II. Hematoloji ‹lk Basamak Kursu Bildiri Özet Kitab›, Kemer - Antalya s.37-45. 2002.
  • 14. E. Atay, M. Akin, E.Yüzkollar, Z. Atay, E. Dursun; Ö. Ceran. Neonatal Pur￾pura Fulminans Associated with Early-Onset Gram- Negative Entero￾bacter Septicemia: A Case Report. Int.pediat 2000: 162-3.
  • 15. Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic res￾ponse. Semin Thromb Hemost(abst) 1996;22:69-88.
  • 16. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 657-66.
  • 17. Wada H, abe Y, Nishioka J, Tomatsu H, Nobori T. Criteria for diagnosing DIC: Rinsho Byori (abst) 2002; 50:273.
  • 18. Levi M. Current understanding of disseminated intravascular cagulati￾on. Br. J. Haem 2004; 124: 567-76.
  • 19. Levi M, de Jorge E, van der Poll T, Cate H. Novel approaches to the ma￾nagement of disseminated intravascular coagulation. (abst) Crit Care Med 2000; 28:20.
  • 20. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic Therapy in Children Chest 2001; 119:344-70.
  • 21. Celkan T. Çocukluk ça¤›nda kal›tsal nedenli tromboz. Türk Pediatri Arfli￾vi 2003; 38:131-45.
  • 22. Dix D, Marzinotto V, Leaker M, The use of low molecular weight hepa￾rin in pediatric patients: a prospective cohort study. J Pediatr 2000:136; 439-45.
  • 23. Levi M, de Jorge E, van der Poll T. Therapeutic intervention in dissemi￾nated intravascular coagulation: have we made any progress in the last millennium? Blood Rev 2002; 16:29-34.
  • 24. Lignell A, Siegbahn A, Stridsberg M, Pauksen K, Gedeborg R, Sjolin J. Low utilization of unactivated protein C in a patient with meningococ￾cal septic shock and disseminated intravascular coagulation. Acta Anaesthesiol Scand 2003; 47:897-900.
  • 25. Rawicz M, Sitkowska B, Rudzinska I, Kornacka MK, Bochenski P. Recombinant human activated protein C for severe sepsis in a neonate. Med Sci Monit. (abs) 2002;8:90.

Yaygın Damar İçi Pıhtılaşması

Yıl 2004, Cilt: 2 Sayı: 4, 117 - 121, 01.12.2004

Ünsal Günay Birol Baytan Adalet Meral Güneş Özcan Bör

Öz

Yaygın damar içi pıhtılaşması YDP ; Sepsis, şok, şiddetli dehidratasyon gibi çeşitli olayların seyri sırasında koagülasyon mekanizmasının sistemik olarak aktive edilmesi sonucu damar içinde yaygın fibrin depolanması, hemostatik elemanların parçalanmaı ve tüketimi ile karakterize bir sendromdur 1 . Bu sendrom ‘’Disssemine intravasküler Koagulasyon DİK ’’ olarak da isimlendirilmektedir.

Kaynakça

  • 1. Goodnight SH, Griffin JH. Hereditary Trombophilia. In: Beutler E, Licht￾man MA, Coller BS, Seligsohn U (ed.). Willams Hematology. 6th editi￾on. Pensilvellia. McGraw-Hill; 2001. p.1697-707.
  • 2. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
  • 3. Cate T.H, Somme›jer D. W, Lev› M. Disseminated intravascular caogu￾lation in the new millennium. The Hematology Journal 2002; 3:86-95.
  • 4. Sjoukje H. S, Spek C. A, Cate T.H. Disseminated intravascular caogula￾tion. The Hematology Journal 2003; 4:295-302.
  • 5. Abildgaard CF, JJ Corrigan, RA Seter, JV Simone, I Schulman. Menin￾gococcemia assosiated with intravascular coagulation. Pediatrics (abst) 1967; 40:78.
  • 6. F Fourrier, C Chopin, J Goudemand, S Hendryx, C Caron, A Rime, A Ma￾rey. Septic shock, multiple organ failure, and disseminated intravascu￾lar coagulation. Compared patterns of antitrombin, protein C, and pro￾tein S deficiencies. Chest 2000; 101: 816-23.
  • 7. Levi M, Cate H, Van Der Poll T, Deventer S. J. Pathogenesis of dissemi￾nated intravascular coagulation in sepsis. N Engl J Med 1993; 8: 1132-4.
  • 8. Bick R.L, Strauss J.F, Frenkel E.P. Thrombosis and hemorrage in onco￾logy patients. Hematology Oncology Clinics North America 2001; 10: 875-907.
  • 9. Levi M, Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-92
  • 10. Stormorken H. ‹nterrelationships between the coagulation, the fibri￾nolytic and the kallikrein and kinin system. Scand. Journal Hematology (abst) 1998; 13:66-9.
  • 11. Rodger L.B, B.A. Frenkel, E.P Frenkel. Diseminated intravaskülar coagu￾lat›on:clinical and pathophysiologial mechanisms and manifestations. 15 th international congress on thrombosis. Stockholm. Bildiri Özet Ki￾tab›. S. 209-17, 1998.
  • 12. Rock A. Consumption Coagulopathy. In: Behrman R.E, Kliegman M.R, Arvin M.A, Nelson W.E (ed.) Nelson Textbook of Pediatrics. 15th.editi￾on. W.B. Saunders company 1996: p 430-31.
  • 13. Karado¤an ‹. Yayg›n damar içi p›ht›laflmas› sendromu. II. Hematoloji ‹lk Basamak Kursu Bildiri Özet Kitab›, Kemer - Antalya s.37-45. 2002.
  • 14. E. Atay, M. Akin, E.Yüzkollar, Z. Atay, E. Dursun; Ö. Ceran. Neonatal Pur￾pura Fulminans Associated with Early-Onset Gram- Negative Entero￾bacter Septicemia: A Case Report. Int.pediat 2000: 162-3.
  • 15. Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic res￾ponse. Semin Thromb Hemost(abst) 1996;22:69-88.
  • 16. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 657-66.
  • 17. Wada H, abe Y, Nishioka J, Tomatsu H, Nobori T. Criteria for diagnosing DIC: Rinsho Byori (abst) 2002; 50:273.
  • 18. Levi M. Current understanding of disseminated intravascular cagulati￾on. Br. J. Haem 2004; 124: 567-76.
  • 19. Levi M, de Jorge E, van der Poll T, Cate H. Novel approaches to the ma￾nagement of disseminated intravascular coagulation. (abst) Crit Care Med 2000; 28:20.
  • 20. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic Therapy in Children Chest 2001; 119:344-70.
  • 21. Celkan T. Çocukluk ça¤›nda kal›tsal nedenli tromboz. Türk Pediatri Arfli￾vi 2003; 38:131-45.
  • 22. Dix D, Marzinotto V, Leaker M, The use of low molecular weight hepa￾rin in pediatric patients: a prospective cohort study. J Pediatr 2000:136; 439-45.
  • 23. Levi M, de Jorge E, van der Poll T. Therapeutic intervention in dissemi￾nated intravascular coagulation: have we made any progress in the last millennium? Blood Rev 2002; 16:29-34.
  • 24. Lignell A, Siegbahn A, Stridsberg M, Pauksen K, Gedeborg R, Sjolin J. Low utilization of unactivated protein C in a patient with meningococ￾cal septic shock and disseminated intravascular coagulation. Acta Anaesthesiol Scand 2003; 47:897-900.
  • 25. Rawicz M, Sitkowska B, Rudzinska I, Kornacka MK, Bochenski P. Recombinant human activated protein C for severe sepsis in a neonate. Med Sci Monit. (abs) 2002;8:90.
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Collection
Yazarlar

Ünsal Günay Bu kişi benim

Birol Baytan Bu kişi benim

Adalet Meral Güneş Bu kişi benim

Özcan Bör Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2004
Yayımlandığı Sayı Yıl 2004 Cilt: 2 Sayı: 4

Kaynak Göster

APA Günay, Ü., Baytan, B., Güneş, A. M., Bör, Ö. (2004). Yaygın Damar İçi Pıhtılaşması. Güncel Pediatri, 2(4), 117-121.
AMA Günay Ü, Baytan B, Güneş AM, Bör Ö. Yaygın Damar İçi Pıhtılaşması. Güncel Pediatri. Aralık 2004;2(4):117-121.
Chicago Günay, Ünsal, Birol Baytan, Adalet Meral Güneş, ve Özcan Bör. “Yaygın Damar İçi Pıhtılaşması”. Güncel Pediatri 2, sy. 4 (Aralık 2004): 117-21.
EndNote Günay Ü, Baytan B, Güneş AM, Bör Ö (01 Aralık 2004) Yaygın Damar İçi Pıhtılaşması. Güncel Pediatri 2 4 117–121.
IEEE Ü. Günay, B. Baytan, A. M. Güneş, ve Ö. Bör, “Yaygın Damar İçi Pıhtılaşması”, Güncel Pediatri, c. 2, sy. 4, ss. 117–121, 2004.
ISNAD Günay, Ünsal vd. “Yaygın Damar İçi Pıhtılaşması”. Güncel Pediatri 2/4 (Aralık 2004), 117-121.
JAMA Günay Ü, Baytan B, Güneş AM, Bör Ö. Yaygın Damar İçi Pıhtılaşması. Güncel Pediatri. 2004;2:117–121.
MLA Günay, Ünsal vd. “Yaygın Damar İçi Pıhtılaşması”. Güncel Pediatri, c. 2, sy. 4, 2004, ss. 117-21.
Vancouver Günay Ü, Baytan B, Güneş AM, Bör Ö. Yaygın Damar İçi Pıhtılaşması. Güncel Pediatri. 2004;2(4):117-21.